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Abstract
The various cells that support neurons in both the central and peripheral nervous
systems are known collectively as neuroglia, or glia. Astrocytes, a type of glial cell found
exclusively in the central nervous system (i.e. the brain and spinal cord), are particularly
abundant and serve many functions. One of the most important is the role these cells play in
the brain as a defense against harmful substances, many of which can be found in the
environment and make their way into the human body as xenobiotic substances. Elemental
arsenic in its inorganic form occurs naturally throughout the Earth’s crust, but poses a major
health risk worldwide when it is found at elevated levels particularly in groundwater used as
a source for domestic or agricultural use. Exposure to arsenic has been shown to cause a
number of adverse health effects, from cardiovascular and liver damage to neurological
dysfunction, though much less is known about its effects in the brain. Astrocytes are likely to
play a protective role in the form of a barrier capable of detoxifying inorganic arsenic
molecules carried to the brain via the circulatory system. However, the mechanism(s) by
which the process of detoxification occurs has yet to be fully elucidated. Using primary
astrocyte cultures, the present study focused on the role of glutathione, glucose metabolism,
and mitochondria in minimizing the adverse neurological effects of xenobiotic arsenic in
astrocytes. Results show that the introduction of arsenic compounds to cultures of astrocytes
stimulates changes in intracellular glucose metabolism, altering flux of glucose-derived
carbons through the glycolytic and oxidative pathways. The diversion has been indicated to
result in an increased anaplerotic synthesis of glutathione, an important intracellular
tripeptide for xenobiotic defense. In addition, results suggest that mitochondria rely on the
input of acetyl-CoA, which, surprisingly, alludes to the importance of fatty acid metabolism
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as the alternate carbon source for acetyl-CoA in the mitochondrial contribution to
detoxification of arsenic via glutathione synthesis.

Key words: Astrocytes, glutathione, arsenic toxicity, Veterinary Science, School of
Veterinary Medicine and Biological Sciences
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Introduction
Astrocytes as primary defense against xenobiotics
Glial astrocytes in the central nervous system (CNS) play a crucial role, performing a
variety of functions in support of neurons. Astrocytes help to facilitate a stable intracellular
and extracellular environment by maintaining redox status via glutathione (GSH) synthesis,
balance energy metabolism via glycolytic and mitochondrial activity, and function in
neuronal signaling pathways via production, release, and reuptake of neurotransmitter
molecules (1). Ultimately, these dynamic cells constitute the primary defense against
xenobiotic threat in the form of a protective layer of cells known as the blood-brain barrier,
which serves to screen the blood before it reaches highly sensitive neurons. Cellular
processes extending from the cell bodies of astrocytes wrap around capillaries and arterioles
transporting blood carrying nutrients, drugs, and potentially harmful xenobiotic substances
from the circulatory system into the CNS. These processes form a virtually continuous layer
between the bloodstream and the brain that allows astrocytes, functioning as intermediaries,
to take up and metabolize blood contents (5). In the case of harmful xenobiotics, this action
helps to reduce the negative impact on neural function through metabolic detoxification.

Astrocytes and glutathione
GSH, a tripeptide ubiquitous in the body’s cells, is most commonly identified in an
antioxidant capacity as an important reducing agent under conditions of oxidative stress. It
undergoes an oxidation-reduction cycle, in which GSH is oxidized to glutathione disulfide
(GSSG). In astrocytes, it is also exported via multidrug resistance-associated protein 1
(MRP1) for subsequent cleavage and uptake by neurons as cysteine, a precursor which is then
resynthesized to glutathione. Its role in xenobiotic detoxification in astrocytes, however, is
3

less understood. It has been shown in previous studies that biotransformation occurs via
glutathione-S-transferase enzymes to convert arsenic taken up by astrocytes into various
metabolites (3). Another mechanism that has been suggested is the formation of complexes
with inorganic arsenic, thus rendering them less toxic, though this ability as well as the ability
to then export the complexed GS-As adducts via MRP1 have yet to be confirmed in
astrocytes (3).

Glucose metabolism in astrocytes
Most cells in the body, especially in the brain, rely on glucose metabolism for energy
production and survival. Astrocytes, too, rely on these pathways; this is due to the fact that
glucose readily crosses the blood-brain barrier, and is normally present in stable
concentrations in circulation (4). The major pathways of glucose metabolism are glycolysis
and oxidative phosphorylation. In astrocytes these pathways have been shown to be
compartmentalized in distinct regions in the cell: oxidative metabolism, carried out by
mitochondria, takes place in the cell body, while glycolysis is carried out in the cellular
processes due to the inability to house mitochondria, which are approximately twice the
diameter of the processes themselves (4). Oxidative phosphorylation is the primary source of
adenosine triphosphate (ATP), the main energy molecule of cellular metabolism, with a much
larger net yield (32 ATP) compared to glycolysis (2 ATP), yet the cell bodies of astrocytes
comprise only 2% of their volume (4). In conditions of xenobiotic stress, astrocytes increase
glucose flux through both of these pathways (4), though to what extent and for what reason
each is involved in the process of detoxifying arsenic is has not been extensively shown in
astrocytes.
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Arsenic
Arsenic poses a pervasive health risk around the world, contributing to a number of
high-priority and potentially fatal diseases, including cardiovascular disease and cancer, and
has more recently been implicated as a risk factor of neurological disorders. It is found
throughout the Earth’s crust primarily as a natural geologic component, as well as as a result
of anthropogenic activity. Most significantly, however, arsenic is found in groundwater, with
concentrations at their highest and most catastrophic levels particularly in the regions of
Southeast Asia, India, and China (5). In the US, groundwater contamination from arsenic is
particularly prominent in the west and central regions, where it can be detected at levels
meeting or exceeding the maximal safe permissible level of 10 ug/L established by the World
Health Organization in 2011(6). The most common forms of inorganic arsenic detected in
groundwater are the pentavalent [arsenate, As(V)] and in reduced environments, trivalent
[arsenite, As(III)] species (7). These species are represented by sodium arsenate (NaAsO2)
and arsenic trioxide (As2O3), respectively.
Inorganic arsenic compounds are toxic to humans and animals due to their ability to
disrupt the normal function of metabolic processes and a great number of enzymes (8).
Historically, anthropogenic use of arsenic compounds has ranged from cosmetics to the
production of chemical pesticides and herbicides. Exposure through these sources can result
in acute toxicity, though in coming to understand the many adverse health effects of arsenic
its use in such activities has largely been discontinued, whereas chronic exposure to arsenic
as a result of groundwater contamination continues to pose substantial risk (8). Adverse
effects of chronic arsenic exposure include increased risk of multiple types of cancer,
diabetes, and blackfoot disease. Neurological conditions include impaired cognitive
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development and neuropathy (8), though the etiology on a cellular level are as yet largely
unexplored.
Prior Research in the Franco Lab
The direction of the current study was guided in part by findings previously achieved
in the Franco lab, which served as the basis for investigation of the role of mitochondrial
glucose metabolism and GSH in detoxification of harmful xenobiotics in astrocytes.

A. Increase in glutathione prior to cell death

Figure 1. Increase in intracellular glutathione content in astrocytes prior to cell death. Cells treated with NaAsO2 and As2O3 at 0, 2, 5, 10, 20,
50, and 100 μM for 48h. Cells were harvested and analyzed as indicated in Methods and Materials. Astrocytes exhibit increased GSH
content at sub-lethal levels of arsenic, shown as a result of flow cytometry (A) and in statistical analysis of these sub-lethal concentrations
(B). * p < 0.05

Astrocytes were treated with increasing concentrations of NaAsO2 and As2O3 in order
to investigate conditions of arsenic exposure that lead to an increase in intracellular GSH
content. It was found that at sub-lethal concentrations of each of the arsenic treatments (2 μM
for As2O3 and 5 μM for NaAsO2; Figures 1A and B), GSH content increased approximately
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1.6-fold. At greater concentrations, cell membranes were compromised and levels of cell
viability decreased. This demonstrated that just prior to cell death, intracellular GSH
production was likely being upregulated.

B. Arsenic treatment results in a reduced intracellular environment

Figure 2. Treatment with inorganic arsenic compounds causes a reduced intracellular environment in astrocytes. Cells were treated with
concentrations of 0, 5, 10, 15, and 20 μM for 48h and analyzed as described previously (10). At concentrations of 5 μM for As2O3 and 10
μM for NaAsO2, the intracellular redox status showed a reduced environment (A and B).

Upon treatment with increasing concentrations of As2O3 and NaAsO2, analysis of
oxidation-reduction (redox) status showed the resulting intracellular environments in both the
cytoplasm and mitochondria (Figures 2A and B, respectively) to be reduced, again reaching
maxima at similar respective sub-lethal concentrations. This indicates the presence of a
higher concentration of the reduced form of glutathione, GSH, versus to its oxidized form,
GSSG, and suggests the role of GSH in detoxification to involve a metabolic pathway other
than redox cycling as this would instead deplete GSH content as it is converted to GSSG.

7

C. Glutathione synthesis via cytosolic and mitochondrial glucose metabolism

Rose, J., et al. (9)
Figure 3. Glutathione is synthesized via both glycolytic and oxidative metabolism. Cells were incubated in media containing labeled
13C-glucose. After 48h, cells were harvested and analyzed using NMR spectroscopy. Glycine and cysteine from glycolysis and glutamate
from oxidative phosphorylation were utilized in the synthesis of GSH. (A) Following treatment with arsenic, separate cell cultures exhibited
increased intracellular GSH content (B). * p < 0.05

Metabolomic analysis by nuclear magnetic resonance (NMR) spectroscopy allowed
investigators to track the pathways into which extracellular glucose was incorporated in
astrocytes (Figure 3A). Cells were treated with labeled 13C-glucose in culture media, which
was then taken up and metabolized, where metabolic substrates and products containing the
labeled isotope could be identified. The results of the NMR analysis revealed that astrocytes
rely both on glycolysis in the cytoplasm and oxidative phosphorylation in the mitochondria to
synthesize glutathione. It was shown that cataplurotic glutamate exported from mitochondria
was combined with glycine and cysteine (from glycolysis), highlighting the importance of
mitochondrial activity in the biosynthesis of GSH from glucose. NMR analysis also indicated
the same increase in GSH content following sub-lethal treatment at 5 μM NaAsO2 that signals
a potential upregulation of GSH synthesis as astrocytes undergo xenobiotic threat (Figure
3B).
Hypothesis
8

In light of these previous results, the need for further study into the role of GSH
synthesis via mitochondrial glucose metabolism, as well as the mechanism and significance
of the role of GSH in the detoxification of xenobiotics, is addressed in the present study. It is
hypothesized that i) the upregulation of glutathione in the intracellular environment is the
result of increased biosynthesis, involving increased mitochondrial activity, and ii) that the
resulting GSH is then directly complexed with the toxic xenobiotic compound for export
from the cell. Furthermore, in the previous findings it was observed that both arsenic
compounds (i.e. As2O3 and NaAsO2) generated similar toxic effects, though higher
concentrations of NaAsO2 were required to achieve the same response (Figures 1A and B, 2A
and B). Due to ease of acquisition and handling safety it was elected to perform further
experiments using NaAsO2 only, adjusting concentrations accordingly.

Methods and Materials
Astrocyte cell culture
Primary rat astrocytes were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM)/Ham’s F-12 Nutrient Mixture (GIBCO or Hyclone) supplemented with 10% fetal
bovine serum (FBS, Atlanta Biologicals), 2 mM L-glutamine (Hyclone), 1%
streptomycin/penicillin (Hyclone) at 37°C under 5% atmospheric CO2. Cells were cultured in
12-well culture plates for 48 hours, at the end of which they reached monolayer confluency,
verified by microscope. Cells were treated as indicated in the figures. Control conditions
included the appropriate vehicle. Treatments started with fresh media.

Cell viability determination
9

Loss of cell viability was determined using flow cytometry (FACS, Fluorescence
Activated Cell Sorting) by measuring propidium iodide (PI, 1 µg/ml, Life Technologies or

Sigma-Aldrich) and monochlorobimane (mBCl, M) as markers for plasma membrane
integrity loss. PI was detected using BluFl3 or BluFl5 and mBCL was detected using VioFl2
in a BDFACSort (Cytek-DxP-10 upgrade). Data were analyzed using FlowJo 7.6.5 software.
Total cell count set to 10,000. At least 4 experimental replicates were performed.

Statistical analysis
Collected data were analyzed according to statistical criteria by using paired or
unpaired t-test, two-way ANOVA, and the appropriate parametric or non-parametric
normality post-test using SIGMA-PLOT/STAT package. A probability value of p<0.05 was
considered as statistically significant. Data were plotted as mean values of at least 4
experimental replicates ± standard error of the mean (SE) using the same statistical package
for data analysis. Flow cytometry graphs presented are representative of at least 4
experimental replicates.
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Results and Discussion
A. Blocking glutathione synthesis potentiates cell death

Figure 4. Inhibition of GSH synthesis results in cell death. Astrocytes treated as indicated in figures for 48h. Cells experience complete loss
in viability after treatment with 500 μM BSO and 10 μM NaAsO2 (A) compared to modest decrease in viability with 300 μM H2O2. Cells
treated with 6AN were not affected in the presence of NaAsO2 (C) compared to decreased viability with 300 μM H2O2. * p < 0.05

In order to investigate whether it is the biosynthesis of glutathione, rather than redox
cycling, that is most significantly responsible in the detoxification of arsenic, primary
astrocyte cultures were treated with 0 μM, 10 μM, and 20 μM of NaAsO2 and separately with
0 μM and 300 μM hydrogen peroxide (H2O2, an agent of oxidative stress that induces redox
cycling), both with or without buthionine sulfoximine (BSO, 500 μM), an inhibitor of
glutathione synthesis (Figures 4A and B; see Figure 10, Appendix for inhibitor action
diagram and list of compounds used) . Cultures were collected and analyzed as indicated in
Methods and Materials. Treatment with arsenic in the presence of BSO resulted in a complete
loss of cell viability, compared to the reduction in viability following treatment with H2O2.
Therefore, while oxidative stress may have a moderate effect when cells are treated with a
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known oxidizer, the comparatively greater necessity of generating GSH for metabolic
response when astrocytes are treated with arsenic is clear.
In a second set of conditions to establish the priority of GSH synthesis as opposed to
redox cycling, astrocytes were treated with 0 μM and 10 μM NaAsO2 and separately with 0
μM and 300 μM H2O2 with or without 6-aminonicotinamide (6AN, an inhibitor of the pentose
phosphate pathway, PPP; see Figure 10, Appendix) (Figures 4C and D). Again, a similar
comparison can be made. The PPP is in part responsible for replenishing nicotinamide
adenine dinucleotide phosphate (NADPH), and when this pathway is inhibited, the ability of
the cell to recycle oxidized glutathione, GSSG, back to its reduced state is impaired. Cell
viability was not impacted under conditions of arsenic treatment, indicating that response
depends little on the redox status of the cell but instead on an alternative metabolic pathway.
These results suggest that indeed astrocytes rely on glutathione synthesis as opposed to
recycling as the primary response to arsenic toxicity.

B. Glutathione conjugation and export as a complex with arsenic

Figure 5. GSH forms a complex with arsenic compounds before export from the cell. Cells were treated with 0, 5, 10, and 20 μM NaAsO2
and 25 μM MK571 for 48h. As treatment concentrations increased a concentration-dependent decrease in viability was observed. * p < 0.05

To examine the hypothesis of complex formation between arsenic and GSH for export
from the cell, astrocytes were treated with concentrations of 0 μM, 5 μM, 10 μM, and 20 μM
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of NaAsO2 with or without 25 μM MK571, an inhibitor of the MRP1 transport protein that is
responsible for the export of GSH compounds from the cell (Figure 5). Following incubation
and analysis (see Methods and Materials), results show a concentration-dependent decrease in
cell viability compared to control conditions. This supports the hypothesis that GSH does
form adducts with xenobiotic arsenic for export from the cell, which, when this action is
inhibited, would cause an accumulation in the intracellular environment, decreasing cell
survival.

C. Mitochondrial glucose metabolism plays an important role

Figure 7. Glucose metabolism carried out in mitochondria of astrocytes are important in xenobiotic defense. Cells were treated with 0, 5, and
10 μM NaAsO2 and either 10 μM MPP+, 250 μM of rotenone, or 50 μM PQ, or under control conditions, for 48h. At 10 μM NaAsO2, cells
experienced decrease in survival (A). Under separate conditions cells were treated with 0, 10, and 20 μM NaAsO2 with or without UK5099
for 48h. These cells also experienced a decrease at 10 μM NaAsO2. * p < 0.05

Cells were treated with 0 μM, 5 μM, and 10 μM concentrations of NaAsO2 and
concurrent treatment with one of three inhibitors of the electron transport train, used to block
mitochondrial function: 10 μM of 1-methyl-4-phenylpyridinium (MPP+), 250 μM of
rotenone, or 50 μM of paraquat (PQ) (Figure 7A). At 10 μM, the capacity of astrocytes
treated with all three compounds to respond adequately to arsenic was decreased
significantly, while the control remained viable at this concentration. The electron transport
train is linked to the TCA cycle by redox cycling of reducing agents FADH2 and NADH. By
13

preventing this system from supporting the TCA cycle, which generates glutamate via
⍺-ketoglutarate for GSH synthesis, astrocytes are thus subject to arsenic toxicity.
Cell cultures were also treated separately under the same NaAsO2 conditions but with
or without 5 μM UK5099, an inhibitor of MPC1 transport protein, which imports pyruvate
into the mitochondria for conversion into oxaloacetate and subsequent incorporation into the
TCA cycle (Figure 7B). Here it is also evident by the decrease in cell survival at 10 μM of
NaAsO2 that the metabolism of glucose carried out by the mitochondria is vital to
maintaining cell viability in astrocytes in response to arsenic exposure.

D. Mitochondrial conversion of pyruvate to oxaloacetate vs. acetyl-CoA in mitochondria

Figure 8. Pyruvate conversion to oxaloacetate vs. acetyl-CoA. Cells were treated with 0, 10, and 20 μM NaAsO2 for 48h with or without
DCA. There was a moderate reduction in cell viability at 10 μM NaAsO2 compared to the control. * p < 0.05

Astrocyte cultures were treated with 0 μM, 5 μM, and 10 μM of NaAsO2, with or
without 5 μM of dichloroacetate (DCA) (Figure 8), which inhibits the dephosphorylation of
pyruvate dehydrogenase (PDH) via pyruvate dehydrogenase kinase (PDK). By preventing the
dephosphorylation of PDH enzyme, more pyruvate is channeled into the production of
acetyl-CoA for input into the TCA cycle. Alternatively, under normal circumstances,
pyruvate may also be converted to oxaloacetate by pyruvate carboxylase (PC), another TCA
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intermediate. The importance of this second pathway for pyruvate that has been taken up into
the mitochondria was explored in addition to the central hypothesis given the fact that
conversion to oxaloacetate does not occur in neurons, and may be key in the ability of
astrocytes to serve in their defense when harmful xenobiotic compounds such as arsenic are
introduced. It was speculated that causing the preferential conversion of pyruvate instead to
acetyl-CoA may result in a decrease in cell survival when treated with arsenic.The results of
this experiment indicate that at higher levels of arsenic, cell viability decreases slightly;
however, cells were still able to maintain high levels of viability despite the diversion in
mitochondrial glucose metabolism. Thus, without exploring pyruvate conversion to
oxaloacetate further, it cannot be concluded that this contributes especially to astrocytes’
capacity to respond to arsenic exposure while maintaining viability.

E. Free fatty acids support mitochondrial glucose metabolism

Figure 9. Fatty acid oxidation supports astrocyte response to arsenic exposure. Cells were treated with 0, 10, and 20 μM NaAsO2 with or
without 200 μM etomoxir. At 10 μM NaAsO2, cell viability was reduced significantly. * p < 0.05

Acetyl-CoA is also provided by the cytoplasmic conversion of free fatty acids to acyl
carnitine, which is then transported into the mitochondria and metabolized to acetyl-CoA.
The importance of this source of acetyl-CoA was also explored as a potential metabolic
mechanism through which astrocytes defend against xenobiotic threat. Astrocytes were
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treated with concentrations of 0 μM, 5 μM, and 10 μM of NaAsO2, with or without 200 μM
of etomoxir, which inhibits carnitine palmitoyltransferase (CPT1), an enzyme necessary in
the conversion of fatty acid molecules into acyl carnitine. . It was found that by inhibiting the
contribution of this source of acetyl-CoA to the TCA cycle, cell viability was reduced. This
effect was not observed at the same level of arsenic treatment without CPT1 inhibition. This
suggests that fatty acid oxidation, therefore, may be an important source of acetyl-CoA
during detoxification of arsenic and other xenobiotics.

Conclusions
Astrocytes are vital for the defense of the central nervous system against the threat
posed by environmental sources of toxicity. Arsenic is a ubiquitous environmental toxicant,
and has been implicated in a number of adverse health effects resulting from chronic
exposure. While some of these effects have been relatively well explored, effects on the
central nervous system have been less so, particularly with reference to specific mechanisms
of action and the metabolic processes involved. The series of experiments in this study in
which astrocytes were exposed to inorganic arsenic and inhibitors of various metabolic
pathways suspected to play a significant role in astrocyte response to such xenobiotics have
attempted to elucidate these processes. As a result, support has been further given to the
hypothesis that i) the upregulation of GSH biosynthesis is necessary, involving increased
mitochondrial metabolic activity, as opposed to redox activity in the cytoplasm, and ii) that
the resulting GSH is then directly complexed with the toxic xenobiotic compound for export
from the cell.
In addition, the importance of mitochondrial metabolism in astrocytes’ capacity to
detoxify xenobiotics was investigated in terms of fatty acid metabolism, resulting in the
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indication that fatty acid oxidation and the contribution of acetyl-CoA to the TCA cycle as a
result of this pathway is a potentially significant part of the response. Further exploration of
these pathways is needed to confirm the degree to which fatty acid oxidation contributes,
though these results are promising.
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Appendix
Diagram of experimental inhibitor compounds

Figure 10.

Rose, J., et al. (9)

List of experimental compounds
6AN (Alfa Aesar) - blocks pentose phosphate pathway, leading to depletion of NADPH and
thus rendering GSH-GSSG redox recycling unavailable
BSO - blocks glutathione biosynthesis by preventing incorporation of component amino
acids
DCA - inhibits PDK, allowing more pyruvate to be channeled into the production of
acetyl-CoA
Etomoxir - blocks CPT1, inhibiting fatty acid oxidation to TCA input acetyl-CoA in
mitochondria
MPP+ (Sigma-Aldrich) - blocks ETC at Complex I
PQ (Acros Organics) - blocks ETC at Complex I
Rot - blocks ETC at Complex I
MK571 - blocks MRP1 transport, preventing the export from the cell of the GSH-As
complex
UK5099 - blocks MPC1 transport, inhibiting pyruvate transfer into the cell for incorporation
into the TCA cycle by oxaloacetate
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